Cleopatra Hospitals Group results, Q3 2025
Net profit, assets, equity and cash flow for Q3 2025, against the same period a year earlier, from the published financial statements.
Net profit269 millionEGP · +29.8% vs the same period a year earlier
Total assets9.98 billionEGP · +45.8% vs the same period a year earlier
Shareholders' equity3.92 billionEGP · +33.0% vs the same period a year earlier
Operating cash flow772 millionEGP · −5.5% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Q3 2025 was about 269 million EGP, up +29.8% from 207 million EGP in Q3 2024.
- Total assets at the end of Q3 2025 were about 9.98 billion EGP, and shareholders' equity about 3.92 billion EGP.
- Operating cash flow for Q3 2025 was positive at 772 million EGP.
Key lines against the same period a year earlier
This periodQ3 2024Change
Net profit269 million207 million+29.8%
Gross profit829 million591 million+40.3%
Total assets9.98 billion6.84 billion+45.8%
Total liabilities6.06 billion3.9 billion+55.6%
Shareholders' equity3.92 billion2.95 billion+33.0%
Total liabilities and equity9.98 billion6.84 billion+45.8%
Operating cash flow772 million817 million−5.5%
Investing cash flow-709 million-1.1 billion+35.5%
Financing cash flow82.29 million431 million−80.9%
Net change in cash—149 million—
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy